2023-04-17 17:19:14 ET
- Vaxcyte ( NASDAQ: PCVX ) is down ~5% in after-hours trading after announcing it has started an underwritten public offering of common stock and pre-funded warrants.
- The company plans to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering.
- BofA Securities, Jefferies, SVB Securities, Evercore ISI, and Guggenheim are acting as joint book-runners .
- Vaxcyte ( PCVX ) closed up 16% Monday on phase 2 data for VAX-24 .
For further details see:
Vaxcyte down 5% after hours on underwritten public offering